Cargando…

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19

BACKGROUND: Garadacimab, a fully human IgG4 monoclonal antibody, inhibits the kallikrein–kinin pathway at a key initiator, activated coagulation factor XII (FXIIa), and may play a protective role in preventing the progression of COVID-19. This phase 2 study evaluated the efficacy and safety of garad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papi, Alberto, Stapleton, Renee D., Shore, Paul M., Bica, Mihai Alexandru, Chen, Younan, Larbig, Michael, Welte, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064633/ https://www.ncbi.nlm.nih.gov/pubmed/37000214 http://dx.doi.org/10.1007/s00408-023-00615-9

Ejemplares similares

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
por: Pontali, Emanuele, et al.
Publicado: (2021)

Circulating cardiovascular microRNAs in critically ill COVID‐19 patients
por: Garg, Ankita, et al.
Publicado: (2021)

Critical illness neuropathy in severe COVID-19: a case series
por: Bocci, Tommaso, et al.
Publicado: (2021)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Safety of urologic elective surgery in a covid-hospital
por: Blezien, O., et al.
Publicado: (2020)

Junior doctors’ mental health and coronavirus disease safety concerns
por: Bartholomew, Alexandra, et al.
Publicado: (2022)

Outcomes of Surgical Revascularization for Acute Limb Ischemia in COVID-19 Patients Comparing to Noninfected Cohort: A Single-Center Observational Prospective Study
por: Predenciuc, Alexandru, et al.
Publicado: (2023)

Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
por: Pham, Amelie, et al.
Publicado: (2021)

Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2022)

An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023)

A Study on the Safety of Percutaneous Tracheostomy in Patients with Severe Acute Respiratory Syndrome Novel Corona Virus 2 (SARS-nCoV2) Infection: A Single-Center Observational Cohort Study in a CoVID Intensive Care Unit
por: Mylavarapu, Krishna Kumar, et al.
Publicado: (2021)

Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
por: Leeson, Cale E., et al.
Publicado: (2020)

Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
por: Kim, Sohyeon, et al.
Publicado: (2023)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

The age-standardized incidence, mortality, and case fatality rates of COVID-19 in 79 countries: a cross-sectional comparison and their correlations with associated factors
por: Hong, Dongui, et al.
Publicado: (2021)

Impact of COVID-19 on Antimicrobial Use and Resistance in an Urban Safety-Net Community Hospital
por: Lora, Alfredo Mena, et al.
Publicado: (2021)

COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
por: Trinchillo, Assunta, et al.
Publicado: (2022)

Burden and prevalence of prognostic factors for severe COVID-19 in Sweden
por: Gémes, Katalin, et al.
Publicado: (2020)

Clinical and neurophysiological characterization of muscular weakness in severe COVID-19
por: Bax, Francesco, et al.
Publicado: (2021)

Distinct cytokine profiles associated with COVID-19 severity and mortality
por: Dorgham, Karim, et al.
Publicado: (2021)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
por: Boussier, Jeremy, et al.
Publicado: (2022)

Chosen laboratory markers as a determinant of COVID-19 severity
por: Navolokin, Ihor, et al.
Publicado: (2022)

Phospholipid remodeling and its derivatives are associated with COVID-19 severity
por: Wei, Juntong, et al.
Publicado: (2023)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

MitraClip Insertion to Hasten Recovery from Severe COVID-19
por: Nagaraja, Vinayak, et al.
Publicado: (2020)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
por: Li, Xiaochen, et al.
Publicado: (2020)

Abnormality in the NK-cell population is prolonged in severe COVID-19 patients
por: Leem, Galam, et al.
Publicado: (2021)

Preexisting comorbidities shape the immune response associated with severe COVID-19
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
por: Wong, Jane C.Y., et al.
Publicado: (2023)

COVID-19 in the tonsillectomised population
por: Capriotti, Vincenzo, et al.
Publicado: (2021)

The Impact of COVID-19 on Patient Safety: A Survey of Acute-Care Registered Nurses in New Jersey
por: Pogorzelska-Maziarz, Monika, et al.
Publicado: (2021)

Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
por: Yang, Jee Myung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dff52cnnn32k189fumsj0g0l98